NEW YORK, Feb. 2, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of securities of Richtech Robotics Inc. (NASDAQ: RR) between January 27, 2026 and 12:00 PM ET on January 29, 2026, both dates inclusive (the "Class Period"). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than April 3, 2026 in the securities class action first filed by the ...

LOS ANGELES, Feb. 02, 2026 (GLOBE NEWSWIRE) -- Glancy Prongay Wolke & Rotter LLP reminds investors of the upcoming March 9, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Varonis Systems, Inc. (“Varonis” or the “Company”) (NASDAQ: VRNS) common stock between February 4, 2025 and October 28, 2025, inclusive (the “Class Period”). IF YOU SUFFERED A LOSS ON YOUR VARONIS INVESTMENTS, CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUIN ...

Core Viewpoint - Fermi Inc. is facing a class action lawsuit due to alleged misleading statements and omissions regarding its business operations and the Project Matador AI campus, particularly concerning tenant demand and funding commitments [5]. Group 1: Company Overview - Fermi Inc. conducted its initial public offering (IPO) on October 1, 2025, selling 37,375,000 shares at a price of $21.00 per share [2]. - Following the IPO, Fermi's stock price has significantly declined, trading as low as $8.59 per share, representing a 59% decrease from the IPO price [4]. Group 2: Key Events - On December 12, 2025, Fermi announced that the first tenant for its Project Matador AI campus had terminated a $150 million funding agreement, leading to a stock price drop of $5.16 per share, or 33.8%, closing at $10.09 [3]. - The lawsuit alleges that Fermi overstated tenant demand and failed to disclose the reliance on a single tenant's funding commitment, which posed a significant risk to the project's financing [5]. Group 3: Legal Action - Investors who purchased Fermi securities during the class period (October 1, 2025, to December 11, 2025) have until March 6, 2026, to file a lead plaintiff motion in the class action lawsuit [1][6].

Core Viewpoint - A class action lawsuit has been filed against Beyond Meat, Inc. on behalf of investors who acquired its securities during the specified Class Period, highlighting potential legal challenges for the company [1][2]. Group 1: Company Overview - Beyond Meat, headquartered in El Segundo, California, is a developer of plant-based food products, selling meat alternatives under the "Beyond" brand both domestically and internationally [2]. Group 2: Financial Performance and Challenges - As market conditions deteriorated, Beyond Meat committed to achieving EBITDA-positive operations by the end of 2026, focusing on expense reduction, margin improvement, and operational efficiency [3]. - On October 24, 2025, Beyond Meat announced an expected material impairment charge, leading to a stock price drop of over 23% in one trading day [4]. - Subsequent disclosures in November 2025 regarding delayed SEC filings and $77.4 million in impairment charges resulted in further stock declines of approximately 16%, 9%, and 9%, causing significant investor losses [4].

Core Viewpoint - Halper Sadeh LLC is investigating the fairness of the sale of Peakstone Realty Trust to Brookfield Asset Management at $21.00 per share in cash for Peakstone shareholders [1] Group 1: Investigation Details - The investigation focuses on whether Peakstone and its board violated federal securities laws and/or breached fiduciary duties by not obtaining the best possible consideration for shareholders [2] - Concerns include whether Brookfield is underpaying for Peakstone and whether all material information necessary for shareholders to assess the merger consideration was disclosed [2] Group 2: Potential Actions - Halper Sadeh LLC may seek increased consideration for shareholders, additional disclosures, and other relief related to the proposed transaction [3] - The firm operates on a contingent fee basis, meaning shareholders would not incur out-of-pocket legal fees or expenses [3] Group 3: Firm Background - Halper Sadeh LLC represents global investors affected by securities fraud and corporate misconduct, having recovered millions for defrauded investors [4]

Core Viewpoint - Halper Sadeh LLC is investigating the fairness of the merger between Devon Energy Corporation and Coterra Energy Inc. for Devon shareholders, who will own approximately 54% of the combined company upon completion of the transaction [1]. Group 1: Legal Investigation - The investigation focuses on whether Devon and its board violated federal securities laws or breached fiduciary duties by not obtaining the best possible consideration for shareholders and failing to disclose all material information necessary for assessing the merger [3]. - Halper Sadeh LLC may seek increased consideration for shareholders, additional disclosures, and other relief related to the proposed transaction [4]. Group 2: Shareholder Rights - Devon shareholders are encouraged to learn more about their legal rights and options regarding the merger [2].

Core Viewpoint - The F5 class action lawsuit alleges that F5, Inc. and its executives misled investors regarding the company's revenue outlook and growth potential, particularly in light of a significant security incident that impacted its operations and stock price [1][4]. Company Overview - F5, Inc. is a global multi-cloud application security and delivery company that enables customers to deploy, secure, and operate applications both on-premises and via public cloud [3]. Allegations of the Lawsuit - The lawsuit claims that F5 created a false impression of having reliable information about its projected revenue and growth while downplaying risks associated with seasonality and macroeconomic factors [4]. - It is alleged that F5 was experiencing a significant security incident that jeopardized client security and the company's future prospects [4]. - On October 15, 2025, F5 disclosed a security breach involving a nation-state threat actor, leading to a nearly 14% drop in stock price over two trading days [5]. - Following the breach, F5 reported fourth quarter fiscal year 2025 results that fell significantly below market growth expectations for fiscal 2026, resulting in an 11% decline in stock price over two trading days [6]. Legal Process - The Private Securities Litigation Reform Act of 1995 allows any investor who purchased F5 securities during the Class Period to seek appointment as lead plaintiff in the class action lawsuit [7]. - The lead plaintiff represents the interests of all class members and can select a law firm to litigate the case [7]. Law Firm Background - Robbins Geller Rudman & Dowd LLP is a leading law firm specializing in securities fraud and shareholder litigation, having recovered over $2.5 billion for investors in 2024 alone [8].

Core Viewpoint - The Ardent Health class action lawsuit alleges that the company and its executives made misleading statements regarding financial practices and liability reserves, leading to significant stock price declines following revelations of financial discrepancies [3][4]. Group 1: Allegations and Financial Impact - The lawsuit claims that Ardent Health did not accurately assess the collectability of accounts receivable, which inflated reported financial positions [3]. - On November 12, 2025, Ardent Health disclosed a $43 million decrease in third quarter 2025 revenue due to revised accounts receivable assessments, resulting in a nearly 34% drop in stock price [4]. - The company also cut its 2025 EBITDA guidance by approximately 9.6%, from a range of $575 million - $615 million to $530 million - $555 million, citing industry-wide cost pressures [4]. Group 2: Legal Process and Representation - Investors who purchased Ardent Health securities during the specified class period can seek to be appointed as lead plaintiff in the class action lawsuit [5]. - The lead plaintiff will represent the interests of all class members and can choose a law firm to litigate the case [5]. Group 3: Company Overview - Ardent Health operates a network of hospitals and clinics providing various healthcare services [2].

Company Overview - NuScale Power Corporation is a provider of small modular reactor nuclear technology [2] Investigation Details - Robbins Geller Rudman & Dowd LLP is investigating potential violations of U.S. federal securities laws involving NuScale Power Corporation [1] - The investigation focuses on whether NuScale and certain top executives made materially false and/or misleading statements or omitted material information regarding the company's business and operations [2]

Core Viewpoint - The Blue Owl Capital Inc. is facing a class action lawsuit due to alleged violations of the Securities Exchange Act of 1934, with claims of undisclosed liquidity issues and significant pressure on its asset base from BDC redemptions during the specified class period [1][3]. Group 1: Class Action Lawsuit Details - The class action lawsuit is titled Goldman v. Blue Owl Capital Inc., and it allows purchasers of Blue Owl securities between February 6, 2025, and November 16, 2025, to seek appointment as lead plaintiff by February 2, 2026 [1]. - Allegations include that Blue Owl did not disclose meaningful pressure on its asset base from BDC redemptions, leading to undisclosed liquidity issues and potential limitations on redemptions of certain BDCs [3]. Group 2: Financial Performance and Market Reaction - On October 30, 2025, Blue Owl reported third-quarter financial results with fee-related earnings of $376.2 million, missing consensus estimates, and performance revenue falling 33% year over year to $188,000, which led to a decline in stock price [4]. - Following the announcement of a merger agreement on November 5, 2025, between Blue Owl's direct lending businesses, the stock price fell nearly 5% due to concerns over liquidity and redemption limitations [5]. - An article published on November 16, 2025, indicated that OBDC II shareholders could face a 20% reduction in investment value due to the merger, resulting in a nearly 6% drop in Blue Owl's stock price [6].